Pyrimidine compounds and methods of making and using same
US8334292B1 · kind B1 · utility
5Cited by
0References
20Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Jun 14, 2011 |
| Grant date | Dec 18, 2012 |
| Priority date | — |
| Expiry date | Jun 14, 2031 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D405/14
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
Disclosed herein are pyrimidinyl compounds that are contemplated to be modulators of cystic fibrosis transmembrane regulators (CFTR), and methods of making and using same. Also provided are pharmaceutical compositions and methods of treating disorders associated with cystic fibrosis transmembrane regulators, such as airway inflammation, cystic fibrosis, and the like.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.